Use the Back button in your browser to see the other results of your search or to select another record.
Exercise reduces medication for metabolic syndrome management: a 5-year follow-up study |
Morales-Palomo F, Moreno-Cabanas A, Ramirez-Jimenez M, Alvarez-Jimenez L, Valenzuela PL, Lucia A, Ortega JF, Mora-Rodriguez R |
Medicine and Science in Sports and Exercise 2021 Jul;53(7):1319-1325 |
clinical trial |
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
PURPOSE: This study aimed to determine the effects of a 5-yr exercise intervention on metabolic syndrome (MetS) and health-related variables and medication use for MetS management. METHODS: Participants were randomly assigned to an exercise intervention (n = 25, 54 +/- 2 yr, 20% women) or control group (n = 26, 54 +/- 2 yr, 38% women). The intervention lasted 4 months per year and consisted of high-intensity interval training on a cycloergometer thrice a week. Outcomes were MetS z-score and medication use score, MetS-related variables (including blood pressure, blood glucose homeostasis, and lipid profile), and cardiorespiratory fitness (CRF, as determined by maximal oxygen uptake). RESULTS: MetS z-score was similarly reduced over time in both groups (p = 0.244 for group-time interaction). A quasi-significant and significant group-time interaction was found for MetS number of factors (p = 0.004) and CRF (p < 0.001), respectively. Thus, MetS factors tended to decrease over time only in the exercise group with no change in the control group, whereas CRF increased from baseline to 5-yr assessment in the exercise group (by 1.1 MET, p < 0.001) but decreased in the control group (-0.5 MET, p = 0.025). Medicine use score increased twofold from baseline to 5-yr follow-up in the control group (p < 0.001) but did not significantly change (10%, p = 0.52) in the exercise group (p < 0.001 for group-time interaction). The proportion of medicated patients who had to increase antihypertensive (p < 0.001), glucose-lowering (p = 0.036), or total medication (p < 0.0001) over the 5-yr period was lower in the exercise than that in the control group. CONCLUSIONS: Exercise training can attenuate the increase in medication that would be otherwise required to manage MetS over a 5-yr period.
|